Back to Search Start Over

Cannabinoid CB 2 receptor agonist reduces local and systemic inflammation associated with pneumonia-induced sepsis in mice.

Authors :
Souza CF
Borges LB
Oliveira FRMB
Silva PCS
Patricio DO
Rosales TO
Souza NF
Spiller F
Mansur DS
Assreuy J
Sordi R
Source :
European journal of pharmacology [Eur J Pharmacol] 2023 Nov 15; Vol. 959, pp. 176092. Date of Electronic Publication: 2023 Oct 04.
Publication Year :
2023

Abstract

Sepsis is a severe condition secondary to dysregulated host response to infection leading to tissue damage and organ dysfunction. Cannabinoid CB <subscript>2</subscript> receptor has modulatory effects on the immune response. Therefore, this study investigated the effects of a cannabinoid CB <subscript>2</subscript> receptor agonist on the local and systemic inflammatory process associated with pneumonia-induced sepsis. Pneumonia-induced sepsis was induced in mice by intratracheal inoculation of Klebsiella pneumoniae. Tissue and bronchoalveolar lavage (BAL) were collected 6, 24, or 48 h after surgery. Mice were treated with CB <subscript>2</subscript> agonist (AM1241, 0.3 and 3 mg/kg, i.p.) and several parameters of inflammation were evaluated 24 h after sepsis induction. Polymorphonuclear cell migration to the infectious focus peaked 24 h after pneumonia-induced sepsis induction in male and female animals. Septic male mice presented a significant reduction of cannabinoid CB <subscript>2</subscript> receptor density in the lung tissue after 24 h, which was not observed in females. CB <subscript>2</subscript> expression in BAL macrophages was also reduced in septic animals. Treatment of septic mice with AM1241 reduced cell migration, local infection, myeloperoxidase activity, protein extravasation, and NOS-2 expression in the lungs. In addition, the treatment reduced plasma IL-1β, increased IL-10 and reduced the severity and mortality of septic animals. These results suggest that AM1241 promotes an interesting balance in the inflammatory response, maintaining lung function and preventing organ injury. Therefore, cannabinoid CB <subscript>2</subscript> receptors are potential targets to control the excessive inflammatory process that occurs in severe conditions, and agonists of these receptors can be considered promising adjuvants in pneumonia-induced sepsis treatment.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2023 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1879-0712
Volume :
959
Database :
MEDLINE
Journal :
European journal of pharmacology
Publication Type :
Academic Journal
Accession number :
37797676
Full Text :
https://doi.org/10.1016/j.ejphar.2023.176092